<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02176083</url>
  </required_header>
  <id_info>
    <org_study_id>SCP-1</org_study_id>
    <nct_id>NCT02176083</nct_id>
  </id_info>
  <brief_title>Reproductive Health Survivorship Care Plan Pilot</brief_title>
  <official_title>Intervening on Reproductive Health in Young Breast Cancer Survivors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Diego</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, San Diego</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Most young breast cancer patients undergo chemotherapy and/or endocrine therapy, treatments
      that impair ovarian function and result in significant reproductive health late effects.
      These late effects include symptoms of estrogen deprivation (e.g., hot flashes and vaginal
      dryness), which are distressing in young breast cancer survivors (YBCS). The goal of this
      pilot study is to test the feasibility of a 4-week text message based intervention on hot
      flashes and vaginal dryness in YBCS. YBCS will be randomized in a 1:1 ratio to the
      intervention (text messages on hot flash and vaginal dryness management) and control arms.
      All participants will be prompted to provide daily hot flash frequency and severity via text
      messaging. The primary hypothesis is YBCS will have high rates of daily hot flash reporting
      via text messaging. Secondarily, we will compare changes in hot flash frequency, hot flash
      severity and vagina dryness between the intervention and control arms.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">August 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hot flash response rate</measure>
    <time_frame>4 weeks</time_frame>
    <description>Rate of reporting daily hot flashes</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hot flash frequency</measure>
    <time_frame>1 week</time_frame>
    <description>Average hot flash frequency over 4th week on study</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hot flash severity</measure>
    <time_frame>1 week</time_frame>
    <description>Average hot flash severity over 4th week of study</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in hot flash frequency and severity</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vaginal dryness</measure>
    <time_frame>4 weeks</time_frame>
    <description>Vaginal dryness at the end of study; change in vaginal dryness between baseline and end of study</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Female Sexual Function Index (FSFI)</measure>
    <time_frame>4 weeks</time_frame>
    <description>FSFI score in 4th week; change in FSFI score between baseline and 4th week</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression</measure>
    <time_frame>4 weeks</time_frame>
    <description>PHQ8</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Participant satisfaction and burden from text messages</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Menopause-specific quality of life (MENQOL)</measure>
    <time_frame>4 weeks</time_frame>
    <description>MENQOL score in 4th week; change in MENQOL scores between base and 4th week</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Breast Cancer</condition>
  <condition>Hot Flashes</condition>
  <condition>Vaginal Dryness</condition>
  <condition>Estrogen Deprivation Symptoms</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Text message management prompts: YBCS will receive text message prompts on how to manage hot flashes and vaginal dryness</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Control YBCS will not receive text message prompts on managing hot flashes and vaginal dryness</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Text message management prompts</intervention_name>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Breast cancer

          -  Female

          -  Completed primary breast cancer treatment

          -  Age &lt;=45
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Irene Su, MD MSCE</last_name>
    <role>Principal Investigator</role>
    <affiliation>UC San Diego</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UC San Diego</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92093-0901</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UCSD Moores Cancer Center</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92093</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 20, 2014</study_first_submitted>
  <study_first_submitted_qc>June 25, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 26, 2014</study_first_posted>
  <last_update_submitted>December 2, 2015</last_update_submitted>
  <last_update_submitted_qc>December 2, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 3, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, San Diego</investigator_affiliation>
    <investigator_full_name>Hui-Chun Irene Su</investigator_full_name>
    <investigator_title>Assistant Professor of Reproductive Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
    <mesh_term>Hot Flashes</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

